scispace - formally typeset
Open AccessJournal Article

6-Phosphofructo-2-kinase/fructose-2,6-bisphosphatase gene family overexpression in human lung tumor.

Reads0
Chats0
TLDR
The results' clearly demonstrated overexpression of PFKFB gene family isozymes in the lung cancers and they possible role in the Warburg effect.
Abstract
The 6-phosphofructo-2-kinase/fructose-2,6-bisphosphatase (PFKFB) is a family of bifunctional enzymes which is responsible for maintaining the cellular levels of fructose-2,6-bisphosphate, a powerful allosteric activator of glycolysis. Here we report the overexpression of PFKFB-1, -2, -3 and -4 mRNA in the human lung cancers when compared with corresponding normal tissues counterparts as well as PFKFB-4 and -3 protein levels. The lung carcinoma cell line A549, under conditions of normal oxygen tension, has also shown increased transcript levels of PFKFB-2, -3 and -4 when compared to normal tissues. Moreover, hypoxia highly induced the expression of PFKFB-2, PFKFB-3 and especially PFKFB-4 isozymes are highly induced in the lung carcinoma cells. Thus, our results' clearly demonstrated overexpression of PFKFB gene family isozymes in the lung cancers and they possible role in the Warburg effect.

read more

Citations
More filters
Journal ArticleDOI

Review of aerobic glycolysis and its key enzymes – new targets for lung cancer therapy

TL;DR: The discovery of aerobic glycolysis in the 1920s has provided new means and potential therapeutic targets for lung cancer, and can be regulated by many oncoproteins to promote tumor proliferation, migration, and metastasis with dependence or independence of gly colysis.
Journal ArticleDOI

Balancing glycolytic flux: the role of 6-phosphofructo-2-kinase/fructose 2,6-bisphosphatases in cancer metabolism.

TL;DR: The current understanding of the role of PFKFB proteins in the control of cancer metabolism is reviewed and the emerging interest in these enzymes as potential targets for the development of antineoplastic agents is discussed.
Journal ArticleDOI

Crucial role of the pentose phosphate pathway in malignant tumors (Review)

TL;DR: The aim of the present review was to describe the recent discoveries associated with the deregulatory mechanisms of the PPP and glycolysis in malignant tumors, particularly in hepatocellular carcinoma, breast and lung cancer.
Journal ArticleDOI

Identification of a novel glycolysis-related gene signature for predicting metastasis and survival in patients with lung adenocarcinoma

TL;DR: This study reveals a connection between the nine-gene signature and glycolysis and offers a novel biomarker of a poor prognosis and metastasis for LUAD patients.
Journal ArticleDOI

TIGAR, TIGAR, burning bright

TL;DR: By protecting cells from oxidative stress, TIGAR may mediate some of the tumor suppressor activity of p53 but could also contribute to tumorigenesis.
Related Papers (5)